WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Inc Stock Ownership - Who owns Viridian Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Viridian Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2024-01-22476,190$21.00
$10.00MBuy
Lara MeisnerChief Legal Officer2023-06-1627$23.03
$621.81Buy
Lara MeisnerChief Legal Officer2023-06-1627$28.35
$765.45Sell
Lara MeisnerChief Legal Officer2023-06-152,269$28.02
$63.58kSell
Lara MeisnerChief Legal Officer2023-06-152,269$23.03
$52.26kBuy
Lara MeisnerChief Legal Officer2023-06-065,126$25.02
$128.25kSell
Lara MeisnerChief Legal Officer2023-06-065,126$18.51
$94.88kBuy
Lara MeisnerChief Legal Officer2023-06-05499$25.03
$12.49kSell
Lara MeisnerChief Legal Officer2023-06-05499$18.51
$9.24kBuy
Lara MeisnerChief Legal Officer2023-06-021,875$24.21
$45.39kSell

1 of 2

VRDN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRDN insiders and whales buy or sell their stock.

VRDN Shareholders

What type of owners hold Viridian Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC12.15%7,625,542$99.36MInstitution
Logos Global Master Fund LP9.56%6,000,000$78.18MInsider
Paradigm Biocapital Advisors LP7.64%4,794,488$62.47MInstitution
Vr Adviser LLC6.19%3,882,623$50.59MInstitution
Deep Track Capital LP5.79%3,631,728$47.32MInstitution
Blackrock Inc5.46%3,426,450$44.65MInstitution
Bruce Booth5.01%3,142,580$40.95MInsider
Atlas Venture Fund Vii L P5.01%3,142,580$40.95MInsider
Vanguard Group Inc4.78%3,000,948$39.10MInstitution
State Street Corp4.31%2,708,383$35.29MInstitution

1 of 3

VRDN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRDN67.46%32.54%Net Buying
TYRA59.50%40.50%Net BuyingNet Buying
EYPT20.11%79.89%Net SellingNet Buying
RLAY72.36%27.64%Net SellingNet Selling
TNGX59.42%40.58%Net BuyingNet Selling
View Top Biotech Stocks

Viridian Therapeutics Stock Ownership FAQ

Who owns Viridian Therapeutics?

Viridian Therapeutics (NASDAQ: VRDN) is owned by 95.81% institutional shareholders, 46.22% Viridian Therapeutics insiders, and 0.00% retail investors. Logos Global Master Fund LP is the largest individual Viridian Therapeutics shareholder, owning 6.00M shares representing 9.56% of the company. Logos Global Master Fund LP's Viridian Therapeutics shares are currently valued at $76.20M.

If you're new to stock investing, here's how to buy Viridian Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.